Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
27
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TSHA.
Market Data
Market Cap$1.69B
Shares Outstanding325.83M
Float196.96M
Cash$455.41M
Debt$49.26M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 29.9% shares (2026Q1 vs prior)
195 institutional holders · 357.04M shares
#1
MORGAN STANLEY
55.35M shares
#2
Avoro Capital Advisors LLC
43.40M shares
#3
GOLDMAN SACHS GROUP INC
36.06M shares
+ 17 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest46.69M
Days to Cover19.0
% of Float23.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2020-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual TSHA Dilution Snapshot
Taysha Gene Therapies, Inc. (TSHA) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for TSHA: xbrl on 2025-12-31; xbrl on 2020-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: